HAEMATO AG provided earnings guidance for the year 2021. The company expects the positive sales development of the past financial year to continue in the 2021 financial year and anticipate sales growth to EUR 260 million to EUR 290 million and an improvement in EBIT in the current financial year to EUR 7 million to EUR 9 million. The expected significant increase in EBIT in 2021 is the result of implementing the new strategy of focusing on high-margin business areas.